Recombinant factor VIIa enhances platelet deposition from flowing haemophilic blood but requires the contact pathway to promote fibrin deposition

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2516|21|2|266-274

ISSN： 1351-8216

Source： HAEMOPHILIA, Vol.21, Iss.2, 2015-03, pp. : 266-274

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of Bleeding in Patients with Platelet Disorders: Is There a Place for Recombinant Factor VIIa?

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 32, Iss. 1, 2002-05 ,pp. : 37-40

Karger

Access to resources Recommend Favorite

Recombinant Factor VIIa Reduces Bleeding Risk in Patients on Platelet Aggregation Inhibitors Immediately prior to Renal Transplantation – A Retrospective Analysis

By  

Urologia Internationalis, Vol. 78, Iss. 2, 2007-02 ,pp. : 135-139

Karger

Access to resources Recommend Favorite

More on: platelet count and the Use of Recombinant Factor VIIa for the treatment of Bleeding Complications after Hematopoietic Stem Cell Transplantation

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 4, Iss. 1, 2006-01 ,pp. : 288-288

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Evidence behind Inhibitor Treatment with Recombinant Factor VIIa

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 32, Iss. 1, 2002-05 ,pp. : 13-18

Karger

Access to resources Recommend Favorite

Traumatic haemorrhage: a role for recombinant factor VIIa?

By  

ANAESTHESIA, Vol. 64, Iss. 10, 2009-10 ,pp. : 1141-1142

John Wiley & Sons Inc

Access to resources Recommend Favorite